Accelerating Access: Regulatory Support for Advanced Therapies in the UK

28 Jan 2026
Advanced Therapies Stage
  • Smarter Trials: Accelerating ATMP development with AI, in silico models & real-world data 
  • Closer to the Patient: New law enabling decentralised, point-of-care manufacturing 
  • Faster Access: Streamlined innovation pathways with HTA collaboration 
  • Fairer Research: Improving equity and inclusion in ATMP clinical trials 
Speakers
James Pound
James Pound, Interim Executive Director of Innovation and Compliance - MHRA